Sacituzumab govitecan in triple-negative breast cancer.

ABSTRACT:

SUBMITTER: de Nonneville A 

PROVIDER: S-EPMC9263779 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature